Home / ATX.AX : ASX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ATX.AX make money? Does ATX.AX have pricing power? What's the Earnings Whisper? Will ATX.AX profit more as the business scales? What is ATX.AX's management track record? Is ATX.AX's current price justified?

Amplia Therapeutics Limited

AUD 0.12 -$0.05 (-29.41%)

ASX · 15 Sep 2026 07:17 UTC

Previous Close

AUD 0.12

Day Range

AUD 0.12AUD 0.12

Year Range

AUD 0.1AUD 0.28

Market Cap

61.6M

AVG Volume

1.12M

Trailing/Forward PE

-7.19/-

PEG ratio

0.1

Dividend Yield

Next Earnings Date

2026-11-27

Primary Exchange

Australian Securities Exchange

Revenue (AUD)

ATX.AX Revenue (AUD) by quarter
Period	Revenue (AUD)
26 Q4	0
26 Q2	0
25 Q4	2.38M
25 Q2	1.41M
24 Q4	2M
24 Q2	2.45M
23 Q4	-579.89K
23 Q2	1.77M
22 Q4	1.22M
22 Q2	762.54K

Net Income (AUD)

ATX.AX Net Income (AUD) by quarter
Period	Net Income (AUD)
26 Q4	-3.53M
26 Q2	-4.18M
25 Q4	-3.76M
25 Q2	-2.81M
24 Q4	-3.37M
24 Q2	-1.13M
23 Q4	-3.33M
23 Q2	-2.91M
22 Q4	-2.32M
22 Q2	-1.32M

Operating Income (AUD)

ATX.AX Operating Income (AUD) by quarter
Period	Operating Income (AUD)
26 Q4	-6.17M
26 Q2	-7.01M
25 Q4	-3.76M
25 Q2	-2.76M
24 Q4	-5.41M
24 Q2	-3.61M
23 Q4	-2.8M
23 Q2	-4.68M
22 Q4	-3.54M
22 Q2	-2.09M

EBITDA (AUD)

ATX.AX EBITDA (AUD) by quarter
Period	EBITDA (AUD)
26 Q4	-6.12M
26 Q2	-6.77M
25 Q4	-3.91M
25 Q2	-2.8M
24 Q4	-5.29M
24 Q2	-3.49M
23 Q4	-2.67M
23 Q2	-4.6M
22 Q4	-3.54M
22 Q2	-2.08M

Cash Flows (AUD)

ATX.AX Cash Flows (AUD) by quarter
Period	Cash Flows (AUD)
26 Q4	-1.09M
26 Q2	-7.67M
25 Q4	-5.72M
25 Q2	-1.17M
24 Q4	-1.59M
24 Q2	-3.54M
23 Q4	-2.36M
23 Q2	-2.95M
22 Q4	-2.16M
22 Q2	-2.25M

EPS (AUD)

ATX.AX EPS (AUD) by quarter
Period	EPS (AUD)
26 Q4	-0.01
26 Q2	-0.01
25 Q4	-0.01
25 Q2	-0.01
24 Q4	-0.02
24 Q2	-0.01
23 Q4	-0.02
23 Q2	-0.01
22 Q4	-0.01
22 Q2	-0.01

Expenses (AUD)

ATX.AX Expenses (AUD) by quarter
Period	Expenses (AUD)
26 Q4	6.12M
26 Q2	7M
25 Q4	6.15M
25 Q2	4.14M
24 Q4	5.04M
24 Q2	3.57M
23 Q4	2.76M
23 Q2	4.66M
22 Q4	3.55M
22 Q2	2.09M

Cash & Debt (AUD)

ATX.AX Cash & Debt (AUD) by quarter
Period	Cash & Debt (AUD)
26 Q4	27.85M
26 Q2	29.16M
25 Q4	10.86M
25 Q2	4.56M
24 Q4	3.39M
24 Q2	5.66M
23 Q4	9.26M
23 Q2	11.68M
22 Q4	14.61M
22 Q2	3.17M

Debt ratios

ATX.AX Debt ratios by quarter
Period	Debt ratios
26 Q4	1.4
26 Q2	1.53
25 Q4	0.7
25 Q2	0.32
24 Q4	0.11
24 Q2	0.24
23 Q4	0.54
23 Q2	0.74
22 Q4	1.33
22 Q2	0.44

Margins

ATX.AX Margins by quarter
Period	Margins
25 Q4	94.13%
25 Q2	94.95%
24 Q4	83.51%
24 Q2	98.25%
23 Q4	107.65%
23 Q2	98.36%
22 Q4	99.87%
22 Q2	99.78%
21 Q4	99.93%
21 Q2	99.98%

Return on Capital

ATX.AX Return on Capital by quarter
Period	Return on Capital
26 Q4	-8.94%
26 Q2	-9.73%
25 Q4	-17.87%
25 Q2	-22.03%
24 Q4	-29.55%
24 Q2	-7.65%
23 Q4	-21.03%
23 Q2	-15.29%
22 Q4	-10.63%
22 Q2	-10.48%

Shares Outstanding

ATX.AX Shares Outstanding by quarter
Period	Shares Outstanding
26 Q4	513.07M
26 Q2	426.46M
25 Q4	360.71M
25 Q2	253.55M
24 Q4	193.79M
24 Q2	199.62M
23 Q4	199.62M
23 Q2	199.55M
22 Q4	169.5M
22 Q2	125.66M

Book Value Per Share (AUD)

ATX.AX Book Value Per Share (AUD) by quarter
Period	Book Value Per Share (AUD)
26 Q4	0.08
26 Q2	0.1
25 Q4	0.06
25 Q2	0.05
24 Q4	0.06
24 Q2	0.07
23 Q4	0.08
23 Q2	0.1
22 Q4	0.13
22 Q2	0.1

Total Assets (AUD)

ATX.AX Total Assets (AUD) by quarter
Period	Total Assets (AUD)
26 Q4	41.44M
26 Q2	44.54M
25 Q4	22.94M
25 Q2	14.2M
24 Q4	14.85M
24 Q2	17.56M
23 Q4	18.68M
23 Q2	21.84M
22 Q4	24.48M
22 Q2	12.96M

Free Cash Flow Yield

ATX.AX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-25.43%
Sep 26	-25.43%
Sep 26	-23.47%
Aug 26	-21.04%
Aug 26	-20.34%
Aug 26	-21.04%
Aug 26	-20.34%
Jul 26	-23.47%
Jul 26	-21.79%
Jul 26	-22.6%
Jul 26	-21.04%
Jul 26	-20.34%
Jun 26	-28.05%
Jun 26	-32.93%
Jun 26	-34.42%
Jun 26	-31.55%
May 26	-28.05%
May 26	-29.13%
May 26	-25.24%
May 26	-29.13%
May 26	-25.24%
Apr 26	-22.95%
Apr 26	-22.95%
Apr 26	-24.43%
Apr 26	-15.78%
Mar 26	-15.78%
Mar 26	-16.11%
Mar 26	-32.93%
Mar 26	-34.42%
Feb 26	-31.55%
Feb 26	-30.29%
Feb 26	-30.29%
Feb 26	-31.55%
Jan 26	-29.13%
Jan 26	-29.13%
Jan 26	-23.67%
Jan 26	-21.64%
Jan 26	-22.27%
Dec 25	-26.65%
Dec 25	-26.65%
Dec 25	-25.63%
Dec 25	-26.65%
Nov 25	-24.68%
Nov 25	-28.97%
Nov 25	-25.63%
Nov 25	-25.63%
Oct 25	-23.8%
Oct 25	-25.63%
Oct 25	-22.21%
Oct 25	-22.21%
Oct 25	-19.04%
Sep 25	-22.21%
Sep 25	-18.51%
Sep 25	-20.19%
Sep 25	-21.49%
Aug 25	-20.19%
Aug 25	-18.01%
Aug 25	-16.66%
Aug 25	-16.25%
Aug 25	-14.49%
Jul 25	-13.6%
Jul 25	-11.69%
Jul 25	-9.52%
Jul 25	-11.29%
Jun 25	-15.52%
Jun 25	-16.66%
Jun 25	-59.92%
Jun 25	-51.75%
May 25	-68.31%
May 25	-68.31%
May 25	-52.54%
May 25	-63.25%
May 25	-62.1%
Apr 25	-66.97%
Apr 25	-65.68%
Apr 25	-65.68%
Apr 25	-56.92%
Mar 25	-48.79%
Mar 25	-43.79%
Mar 25	-48.1%
Mar 25	-46.78%
Feb 25	-43.79%
Feb 25	-41.65%
Feb 25	-40.66%
Feb 25	-40.18%
Jan 25	-39.26%
Jan 25	-41.65%
Jan 25	-40.66%
Jan 25	-40.18%
Jan 25	-36.33%
Dec 24	-64.12%
Dec 24	-64.89%
Dec 24	-62.62%
Dec 24	-61.9%
Nov 24	-61.2%
Nov 24	-61.2%
Nov 24	-54.96%
Nov 24	-57.91%
Nov 24	-46.83%
Oct 24	-37.14%

Price to Sales

ATX.AX Price to Sales by quarter
Period	Price to Sales
Sep 26	16.27
Sep 26	16.27
Sep 26	17.63
Aug 26	19.66
Aug 26	20.34
Aug 26	19.66
Aug 26	20.34
Jul 26	17.63
Jul 26	18.98
Jul 26	18.31
Jul 26	19.66
Jul 26	20.34
Jun 26	9.95
Jun 26	8.47
Jun 26	8.1
Jun 26	8.84
May 26	9.95
May 26	9.58
May 26	11.05
May 26	9.58
May 26	11.05
Apr 26	12.16
Apr 26	12.16
Apr 26	11.42
Apr 26	17.68
Mar 26	17.68
Mar 26	17.31
Mar 26	8.47
Mar 26	8.1
Feb 26	8.84
Feb 26	9.21
Feb 26	9.21
Feb 26	8.84
Jan 26	9.58
Jan 26	9.58
Jan 26	11.79
Jan 26	12.89
Jan 26	12.53
Dec 25	5.47
Dec 25	5.47
Dec 25	5.69
Dec 25	5.47
Nov 25	5.91
Nov 25	5.04
Nov 25	5.69
Nov 25	5.69
Oct 25	6.13
Oct 25	5.69
Oct 25	6.57
Oct 25	6.57
Oct 25	7.66
Sep 25	6.57
Sep 25	7.88
Sep 25	7.23
Sep 25	6.79
Aug 25	7.23
Aug 25	8.1
Aug 25	8.76
Aug 25	8.98
Aug 25	10.07
Jul 25	10.73
Jul 25	12.48
Jul 25	15.33
Jul 25	12.92
Jun 25	10.57
Jun 25	9.84
Jun 25	2.74
Jun 25	3.17
May 25	2.4
May 25	2.4
May 25	3.12
May 25	2.59
May 25	2.64
Apr 25	2.45
Apr 25	2.5
Apr 25	2.5
Apr 25	2.88
Mar 25	3.36
Mar 25	3.75
Mar 25	3.41
Mar 25	3.51
Feb 25	3.75
Feb 25	3.94
Feb 25	4.03
Feb 25	4.08
Jan 25	4.18
Jan 25	3.94
Jan 25	4.03
Jan 25	4.08
Jan 25	4.51
Dec 24	2.89
Dec 24	2.85
Dec 24	2.95
Dec 24	2.99
Nov 24	3.02
Nov 24	3.02
Nov 24	3.37
Nov 24	3.19
Nov 24	3.95
Oct 24	4.98

Price to Book

ATX.AX Price to Book by quarter
Period	Price to Book
Sep 26	1.56
Sep 26	1.56
Sep 26	1.69
Aug 26	1.88
Aug 26	1.95
Aug 26	1.88
Aug 26	1.95
Jul 26	1.69
Jul 26	1.82
Jul 26	1.75
Jul 26	1.88
Jul 26	1.95
Jun 26	1.34
Jun 26	1.14
Jun 26	1.09
Jun 26	1.19
May 26	1.34
May 26	1.29
May 26	1.49
May 26	1.29
May 26	1.49
Apr 26	1.64
Apr 26	1.64
Apr 26	1.54
Apr 26	2.38
Mar 26	2.38
Mar 26	2.33
Mar 26	1.14
Mar 26	1.09
Feb 26	1.19
Feb 26	1.24
Feb 26	1.24
Feb 26	1.19
Jan 26	1.29
Jan 26	1.29
Jan 26	1.59
Jan 26	1.74
Jan 26	1.69
Dec 25	2.14
Dec 25	2.14
Dec 25	2.23
Dec 25	2.14
Nov 25	2.32
Nov 25	1.97
Nov 25	2.23
Nov 25	2.23
Oct 25	2.4
Oct 25	2.23
Oct 25	2.57
Oct 25	2.57
Oct 25	3
Sep 25	2.57
Sep 25	3.09
Sep 25	2.83
Sep 25	2.66
Aug 25	2.83
Aug 25	3.17
Aug 25	3.43
Aug 25	3.52
Aug 25	3.95
Jul 25	4.2
Jul 25	4.89
Jul 25	6
Jul 25	5.06
Jun 25	4.37
Jun 25	4.07
Jun 25	1.13
Jun 25	1.31
May 25	0.99
May 25	0.99
May 25	1.29
May 25	1.07
May 25	1.09
Apr 25	1.01
Apr 25	1.03
Apr 25	1.03
Apr 25	1.19
Mar 25	1.39
Mar 25	1.55
Mar 25	1.41
Mar 25	1.45
Feb 25	1.55
Feb 25	1.63
Feb 25	1.67
Feb 25	1.69
Jan 25	1.73
Jan 25	1.63
Jan 25	1.67
Jan 25	1.69
Jan 25	1.87
Dec 24	1.43
Dec 24	1.41
Dec 24	1.46
Dec 24	1.48
Nov 24	1.49
Nov 24	1.49
Nov 24	1.66
Nov 24	1.58
Nov 24	1.95
Oct 24	2.46

No video analysis for this stock yet. Request one from our team.

News: ATX.AX

proactiveinvestors.com · 4 Aug 2026

Amplia Therapeutics partners with Lilly on lung cancer combination trial

Amplia Therapeutics Ltd (ASX:ATX, OTCQB:INNMF) has signed a clinical collaboration agreement with Eli Lilly and Company to evaluate its lead drug...

AI Analysis

Amplia Therapeutics Limited

Video analysis: ATX.AX

News: ATX.AX

Amplia Therapeutics partners with Lilly on lung cancer combination trial

Similar companies